Marc van Dijk's most recent trade in MiNK Therapeutics Inc was a trade of 171,078 Stock Option done . Disclosure was reported to the exchange on Jan. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MiNK Therapeutics Inc | Marc van Dijk | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 171,078 | 171,078 | - | - | Stock Option | |
| MiNK Therapeutics Inc | Marc van Dijk | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 15,000 | 15,000 | - | - | Stock Option | |
| MiNK Therapeutics Inc | Marc van Dijk | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 2.32 per share. | 09 Jan 2023 | 51,628 | 51,628 | - | 2.3 | 119,777 | Common Stock |
| MiNK Therapeutics Inc | Marc van Dijk | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.32 per share. | 09 Jan 2023 | 24,265 | 27,363 | - | 2.3 | 56,295 | Common Stock |
| MiNK Therapeutics Inc | Marc van Dijk | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 15,000 | 15,000 | - | - | Stock Option | |
| MiNK Therapeutics Inc | Marc van Dijk | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 62,500 | 62,500 | - | - | Stock Option (Right to Buy) |